Literature DB >> 9598425

An extension of Satterthwaite's approximation applied to pharmacokinetics.

J R Nedelman1, X Jia.   

Abstract

Satterthwaite's approximation for the degrees of freedom of a linear combination of independent mean squares is extended to the case that the mean squares are correlated. The mean squares are sample variances where some of the experimental units have been used in more than one sample. The motivation for such an extension comes from pharmacokinetics. The observations, taken at different time points from a set of animals, are blood drug concentrations. Some animals were sampled at more than one time point. A linear combination of sample means provides an estimate of the population mean area under the concentration-versus-time curve, which is an indicator of drug exposure. An associated linear combination of sample variances provides an estimate of the variance of the area estimator. The behavior of confidence intervals based on the approximation was studied by simulation. The confidence interval for the population mean, constructed by assuming that the variance estimator has a chi-square distribution with the computed degrees of freedom, achieved close to its nominal 95% coverage, justifying the extension of Satterthwaite's approximation.

Mesh:

Year:  1998        PMID: 9598425     DOI: 10.1080/10543409808835241

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  16 in total

1.  Biodistribution of etanercept to tissues and sites of inflammation in arthritic rats.

Authors:  Xi Chen; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Drug Metab Dispos       Date:  2015-04-01       Impact factor: 3.922

2.  Pharmacokinetic assessment of efflux transport in sunitinib distribution to the brain.

Authors:  Rajneet K Oberoi; Rajendar K Mittapalli; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2013-10-10       Impact factor: 4.030

3.  Brain Distribution of a Novel MEK Inhibitor E6201: Implications in the Treatment of Melanoma Brain Metastases.

Authors:  Gautham Gampa; Minjee Kim; Nicholas Cook-Rostie; Janice K Laramy; Jann N Sarkaria; Linda Paradiso; Louis DePalatis; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2018-02-02       Impact factor: 3.922

4.  Biodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer models.

Authors:  Ana Vanessa Nascimento; Florence Gattacceca; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Nanomedicine (Lond)       Date:  2016-03-16       Impact factor: 5.307

5.  Pharmacokinetic mAb-mAb interaction: anti-VEGF mAb decreases the distribution of anti-CEA mAb into colorectal tumor xenografts.

Authors:  Lubna Abuqayyas; Joseph P Balthasar
Journal:  AAPS J       Date:  2012-04-18       Impact factor: 4.009

6.  The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain.

Authors:  Sagar Agarwal; Ramola Sane; John R Ohlfest; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2010-10-15       Impact factor: 4.030

7.  Bayesian approach to estimate AUC, partition coefficient and drug targeting index for studies with serial sacrifice design.

Authors:  Tianli Wang; Kyle Baron; Wei Zhong; Richard Brundage; William Elmquist
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

8.  Effects of replacement of factor VIII amino acids Asp519 and Glu665 with Val on plasma survival and efficacy in vivo.

Authors:  Matthew P Kosloski; Krithika A Shetty; Hironao Wakabayashi; Philip J Fay; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2014-06-17       Impact factor: 4.009

9.  Investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse.

Authors:  Nagdeep Giri; Naveed Shaik; Guoyu Pan; Tetsuya Terasaki; Chisato Mukai; Shinji Kitagaki; Naoki Miyakoshi; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2008-04-28       Impact factor: 3.922

10.  Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer.

Authors:  Lubna Abuqayyas; Joseph P Balthasar
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-11-27       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.